|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/192 | (2006.01) |
| (11) | Number of the document | 2074992 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09156199.3 |
| Date of filing the European patent application | 2006-04-07 | |
| (97) | Date of publication of the European application | 2009-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 669699 P | 2005-04-08 | US |
| (72) |
Ju, Tzuchi, R., US
Davila, Claudia, M., US
Engh, Kevin, R., US
Gao, Yi, US
Gustavson, Linda, E., US
Jayaraman, Shyamala, C., US
Leblond, David, US
Lee, Dennis, Y., US
|
| (73) |
ABBOTT LABORATORIES,
100 Abbott Park Road, Abbott Park, IL 60064-3500,
US
|
| (54) | Oral pharmaceutical formulations comprising salts of fenofibric acid |
| Oral pharmaceutical formulations comprising salts of fenofibric acid |